Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pneumococcal Antigenic Polysaccharide Substances from Animal Tissues

View through CrossRef
Summary Polysaccharide-containing fractions have been prepared from 12 organs and tissues of mice 2 to 3 weeks after injection of 0.5 mg of specific pneumococcus polysaccharide type I, II, or III, an amount known to produce immunological paralysis. The materials stimulated a high degree of immunity in mice against the homologous pneumococcus infection. Similar fractions prepared from tissues of normal mice were devoid of immunizing ability. Those from most tissues of immunized mice (after a 0.002-mg dose of specific polysaccharide) were found to stimulate a low degree of immunity. Tests of similar polysaccharide-containing fractions from tissues of albino and C3H mice 8 to 9 months after a “paralyzing” injection of specific polysaccharide showed that but little type I antigenicity remained, and no type III, but that high titer immunity against type II could still be induced by the homologous polysaccharides isolated from both albino and C3H strains of mice. In one experiment similar fractions prepared from organs and tissues of guinea pigs and rabbits injected with pneumococcal polysaccharides, especially type II, stimulated some immunity in mice against homologous pneumococcus infection.
Title: Pneumococcal Antigenic Polysaccharide Substances from Animal Tissues
Description:
Summary Polysaccharide-containing fractions have been prepared from 12 organs and tissues of mice 2 to 3 weeks after injection of 0.
5 mg of specific pneumococcus polysaccharide type I, II, or III, an amount known to produce immunological paralysis.
The materials stimulated a high degree of immunity in mice against the homologous pneumococcus infection.
Similar fractions prepared from tissues of normal mice were devoid of immunizing ability.
Those from most tissues of immunized mice (after a 0.
002-mg dose of specific polysaccharide) were found to stimulate a low degree of immunity.
Tests of similar polysaccharide-containing fractions from tissues of albino and C3H mice 8 to 9 months after a “paralyzing” injection of specific polysaccharide showed that but little type I antigenicity remained, and no type III, but that high titer immunity against type II could still be induced by the homologous polysaccharides isolated from both albino and C3H strains of mice.
In one experiment similar fractions prepared from organs and tissues of guinea pigs and rabbits injected with pneumococcal polysaccharides, especially type II, stimulated some immunity in mice against homologous pneumococcus infection.

Related Results

Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Background: In the Democratic Republic of Congo (DRC), the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in 2011 through a three-dose schedule, targeting infants ...
Evolving Landscape of Paediatric Pneumococcal Meningitis in Argentina (2013-2023)
Evolving Landscape of Paediatric Pneumococcal Meningitis in Argentina (2013-2023)
The introduction of pneumococcal conjugate vaccination (PCV) into the Argentinian Childhood National Immunization Program in 2012 marked a significant milestone in public health. O...
Evolving Landscape of Paediatric Pneumococcal Meningitis in Argentina (2013–2023)
Evolving Landscape of Paediatric Pneumococcal Meningitis in Argentina (2013–2023)
The introduction of pneumococcal conjugate vaccination (PCV) into the Argentinian Childhood National Immunization Program in 2012 marked a significant milestone in public health. O...
Changes and determinants of pneumococcal vaccine uptake in Ethiopia
Changes and determinants of pneumococcal vaccine uptake in Ethiopia
Abstract Background: Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally. It is one of the top five causes ...
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
Objective: To review the immurtogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in pediatric patients. Data Sources: A MEDLINE search...
Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits
Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits
Granulocytopenia seen during human pneumococcal disease is associated with a worsened prognosis. Streptococcus pneumoniae type 1 reduces circulating granulocytes and induces pulmon...
Animal welfare in Europe and Iran: policy perspective and society
Animal welfare in Europe and Iran: policy perspective and society
Intensive animal production systems are compromising current animal welfare standards. Societies' growing concerns regarding how animals are raised have resulted in continuous poli...

Back to Top